Bone Cancer Panel (ATCC^® TCP-1009^™)

HOS, ATCC CRL-1543

A-673, ATCC CRL-1598

SK-PN-DW, ATCC CRL-2139

U-2 OS, ATCC HTB-96

Saos-2, ATCC HTB-85

Biological understanding of top genetic alterations across tumor types

Validation and characterization of potential cancer driver genes

Functional profiling and molecular profiling of subtype-specific cancer cell lines

Testing small molecules or biologics for cancer drug development

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

A panel of 5 bone cancer cell lines with varying degrees of genetic complexity. Four lines contain genomic mutations in one or more of the following genes according to the Sanger COSMIC database: CDKN2A, BRAF, TP53, RB1, and PTEN. One cell line without coding mutations serves as a control.